• Latest Posts

TrialSpark acquires immunodermatology portfolio and creates Libertas Bio

In Depth 2 Nov 2023

How French pharma giant Sanofi is betting big on AI

FDA approves Beyfortus ahead of 2023-24 RSV season

SandboxAQ launches new division to boost drug development

Sanofi drug reduces disease activity in relapsing MS

Sanofi adds diabetes drug through Provention Bio $2.9B acquisition

Expert Advice 2 Mar 2023

5 steps to strategic partnerships for healthtech startups

Sanofi hemophilia drug gets FDA approval

The Metamorphosis of Biopharmaceutical Innovation #BIO-Europe2015

Sanofi-Genzyme: Still successful 5 years after the acquisition?

Sanofi Invests €80M in mRNA Cancer Vaccine Company

Dupixent gets EU nod for children with severe atopic dermatitis